Table of Content

Table of Contents

1. Executive Summary

2. Global Biologics Targeting CCR4 Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Biologics Targeting CCR4 Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Biologics Targeting CCR4 Market by Type
3.3.1: Monoclonal Antibodies
3.3.2: Small Molecule Chemicals
3.4: Global Biologics Targeting CCR4 Market by Application
3.4.1: Sezary Syndrome
3.4.2: Mycosis Fungoides

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Biologics Targeting CCR4 Market by Region
4.2: North American Biologics Targeting CCR4 Market
4.2.1: North American Market by Type: Monoclonal Antibodies and Small Molecule Chemicals
4.2.2: North American Market by Application: Sezary Syndrome and Mycosis Fungoides
4.3: European Biologics Targeting CCR4 Market
4.3.1: European Market by Type: Monoclonal Antibodies and Small Molecule Chemicals
4.3.2: European Market by Application: Sezary Syndrome and Mycosis Fungoides
4.4: APAC Biologics Targeting CCR4 Market
4.4.1: APAC Market by Type: Monoclonal Antibodies and Small Molecule Chemicals
4.4.2: APAC Market by Application: Sezary Syndrome and Mycosis Fungoides
4.5: ROW Biologics Targeting CCR4 Market
4.5.1: ROW Market by Type: Monoclonal Antibodies and Small Molecule Chemicals
4.5.2: ROW Market by Application: Sezary Syndrome and Mycosis Fungoides

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Biologics Targeting CCR4 Market by Type
6.1.2: Growth Opportunities for the Global Biologics Targeting CCR4 Market by Application
6.1.3: Growth Opportunities for the Global Biologics Targeting CCR4 Market by Region
6.2: Emerging Trends in the Global Biologics Targeting CCR4 Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Biologics Targeting CCR4 Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biologics Targeting CCR4 Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Kyowa
7.2: RAPT Therapeutics Hanmi Pharmaceutical
7.3: Eight Plus One Pharmaceutical
7.4: Merck